Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Interim Management Statement

28 Nov 2014 07:00

RNS Number : 2753Y
Gleeson(M J)Group PLC
28 November 2014
 



Gleeson (MJ) Group PLC

(GLE.L)

 

Interim Management Statement

 

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces its Interim Management Statement, covering the period from 1 July 2014 to 31 October 2014.

 

Gleeson has two divisions:

 

· Gleeson Homes An urban regeneration specialist in the North of England, with a particular focus on low cost family homes

 

· Gleeson Strategic Land A strategic land promotion business, mainly in the South of England, that enhances the value of land through the planning process and sells it to developers

 

Gleeson Homes

 

The market conditions for Gleeson Homes remain healthy, with strong customer demand in all of our regions.

 

The business performed strongly during the period with 206 completions (2013: 132). The current forward order book totals 360 units (2013: 275 units). The Board expects to record an increase in completions in the year to 30 June 2015 of not less than 25% against the prior year total of 561 units.

 

The business currently has 40 active sites, compared with 33 in the corresponding period, with a further net 6 sites due to open by 30 June 2015. Gleeson Homes currently has a land pipeline of 5,116 plots, of which 3,457 are owned and 1,659 are conditionally purchased, along with a further 1,700 further plots actively being considered.

 

The Government's Help to Buy schemes remains popular, with 45% of customers taking advantage of the scheme to assist in the purchase of their home. In addition, our own bespoke purchaser assistance packages continue to be attractive.

 

Gleeson Strategic Land

 

Gleeson Strategic Land consists of 66 sites, totalling 3,913 gross acres, which have the potential to deliver approximately 21,100 units.

 

The division performed in line with expectations during the period, enhancing its portfolio, progressing sites through the planning system, and benefiting from the continuing improvement in the prices that developers are willing to pay for green field residential land in the South of England.

 

There are currently eight sites with planning permission or a resolution to grant permission. Six of these sites, which will deliver 643 plots, are being progressed for sale in the current financial year.

 

In addition, there are 13 sites where the division is currently awaiting either the determination of a planning application or the outcome of a planning appeal. It may also be possible to sell a number of these sites in the current financial year.

 

Outlook

 

The Board expects results for H1 2014 to show a strong increase over H1 2013. Based on the current level of trading in Gleeson Homes and the potential for further site sales in Gleeson Strategic Land in the second half, the Board now believes that the out-turn for the year to 30 June 2015 will exceed current expectations.

 

 

28 November 2014

Enquiries:

MJ Gleeson Group plc

Tel: +44 1252 360 300

Jolyon Harrison

Chief Executive Officer

Alan Martin

Chief Financial Officer

Instinctif

Tel: +44 20 7457 2020

Mark Garraway

Helen Tarbet

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Gillian Martin

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMZMVRNGDZG
Date   Source Headline
20th Feb 20189:37 amRNSHolding(s) in Company
19th Feb 20187:00 amRNSHalf-year Report
7th Feb 20184:40 pmRNSSecond Price Monitoring Extn
7th Feb 20184:35 pmRNSPrice Monitoring Extension
7th Feb 20182:21 pmRNSDirector/PDMR Shareholding
31st Jan 20187:00 amRNSTotal Voting Rights
10th Jan 20182:10 pmRNSDirector/PDMR Shareholding
4th Jan 20187:00 amRNSTrading Update
29th Dec 20177:00 amRNSTotal Voting Rights
8th Dec 201711:51 amRNSDirector/PDMR Shareholding
8th Dec 20178:53 amRNSDirector/PDMR Shareholding
7th Dec 20174:26 pmRNSResult of AGM
7th Dec 20177:00 amRNSAGM Statement
30th Nov 20177:00 amRNSTotal Voting Rights
23rd Nov 20175:48 pmRNSDirector/PDMR Shareholding
23rd Nov 20175:44 pmRNSHolding(s) in Company
8th Nov 20174:54 pmRNSDirector/PDMR Shareholding
8th Nov 20174:43 pmRNSHolding(s) in Company
8th Nov 20174:25 pmRNSDirector/PDMR Shareholding
6th Nov 20177:00 amRNSNotice of AGM
31st Oct 20177:00 amRNSTotal Voting Rights
6th Oct 20172:07 pmRNSDirector/PDMR Shareholding
4th Oct 201711:31 amRNSExercise of Options, TVR & Director/PDMR Dealings
29th Sep 20177:00 amRNSTotal Voting Rights
26th Sep 20174:06 pmRNSPerformance Share Plan Award to Directors
25th Sep 20177:00 amRNSFinal Results
8th Sep 20174:35 pmRNSPrice Monitoring Extension
7th Sep 20179:59 amRNSDirector/PDMR Shareholding
31st Aug 20177:00 amRNSTotal Voting Rights
23rd Aug 201712:07 pmRNSSecond Price Monitoring Extn
23rd Aug 201712:02 pmRNSPrice Monitoring Extension
22nd Aug 20174:35 pmRNSPrice Monitoring Extension
9th Aug 20179:13 amRNSDirector/PDMR Shareholding
31st Jul 20177:00 amRNSTotal Voting Rights
18th Jul 20174:55 pmRNSDirector/PDMR Shareholding
7th Jul 201710:06 amRNSDirector/PDMR Shareholding
5th Jul 20177:00 amRNSTrading Update
30th Jun 20177:00 amRNSTotal Voting Rights
6th Jun 20175:17 pmRNSDirector/PDMR Shareholding
31st May 20177:00 amRNSTotal Voting Rights
25th May 20171:27 pmRNSDirector/PDMR Shareholding
11th May 20171:11 pmRNSDirector/PDMR Shareholding
28th Apr 20177:00 amRNSTotal Voting Rights
24th Apr 20178:49 amRNSHolding(s) in Company
6th Apr 20176:11 pmRNSDirector/PDMR Shareholding
31st Mar 20177:00 amRNSTotal Voting Rights
7th Mar 20175:10 pmRNSDirector/PDMR Shareholding
3rd Mar 20176:14 pmRNSHolding(s) in Company
28th Feb 20177:00 amRNSTotal Voting Rights
27th Feb 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.